Bixiye
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Natiijooyinka Raadinta
Soo bandhiga 3331 - 3340 ee natiijooyinka 3688
Bixiye
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
Alternative Dosage Form - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
P1-25 ICD-10 Surgical Procedure Code Edits Claims Revenue Code 036xType of Bill 11x 18x 21x
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2025
Bixiye
P2-25 Reimbursement Rate Changes Coverage Pharmacist Services
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2025
Bixiye
P3-25 Medical Policy Updates Coupe Health and Self-Funded Benefit Plans Managed by BCBS AL
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2025
Bixiye
QP87-24 MHCP Pharmacy Benefit Exclusion for Aurlumyn™, MydCombi™, paclitaxel protein-bound particles, Pavblu™ and Vyloy®
Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2024
Bixiye
QP88-24 Commercial Pharmacy Benefit Exclusion for Aurlumyn™, MydCombi™, Pavblu™ and Vafseo®
Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2024
Bixiye
QP89-24 TriWest Healthcare Alliance (TriWest) Partnership
Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2024
Bixiye
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025